Focus: Inari Medical is a medical device company specializing in catheter-based technologies for treating venous thromboembolism (VTE), including pulmonary embolism and deep vein thrombosis. The company operates in the cardiovascular and respiratory space with a focus on minimally invasive mechanical thrombectomy solutions.
Profile data last refreshed 10h ago · AI intelligence enriched 3w ago
A specialized device innovator with strong product-market focus but limited hiring and opaque financial health—suitable for early-career professionals seeking deep technical expertise in a niche, but risky for those seeking rapid growth or clear career runway.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Inari Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Inari Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo